Position in ARVN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$122,398
-$261,249 QoQ
Shares Held
11,547
-64.3% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
6 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ARVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Numerai GP LLC holds $4,852,067 across 6 Biotechnology names. ARVN ranks #6 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
13,984 | $2,643,675 | |
| 2 | DNA |
Ginkgo Bioworks Holdings, Inc.
|
175,670 | $1,076,857 | |
| 3 | RPRX |
Royalty Pharma plc
|
10,641 | $510,448 | |
| 4 | SEPN |
Septerna, Inc.
|
15,082 | $362,420 | |
| 5 | FTRE |
Fortrea Holdings Inc.
|
14,466 | $136,269 | |
| 6 | ARVN |
Arvinas, Inc.
This page
|
11,547 | $122,398 |
All Filings in ARVN
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $122,398 | 11,547 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $383,647 | 32,348 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $578,669 | 67,919 | Shares | Sole | 2025-11-14 | |
| 2023-09-30 | $243,437 | 12,395 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,226,798 | 130,008 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $699,364 | 25,599 | Shares | Sole | 2023-05-12 | |
| No filing history on record for this holder in this stock. | ||||||